GeneDx Holdings Corp.
WGSNasdaqCIK 1818331HealthcareFiscal year ends Dec 31
Reports and events: 126 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0316:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051878 |
| 2026-08-0316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051852 |
| 2026-06-2308:35 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-044806 |
| 2026-06-1608:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-043431 |
| 2026-05-2217:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-26-003685 |
| 2026-05-1519:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-26-000350 |
| 2026-05-1121:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-26-000275 |
| 2026-05-0416:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001818331-26-000041 |
| 2026-05-0416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-26-000039 |
| 2026-04-3016:09 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001818331-26-000030 |
| 2026-03-0207:02 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001818331-26-000021 |
| 2026-02-2308:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001818331-26-000015 |
| 2026-02-2308:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-26-000014 |
| 2026-01-1217:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-26-000005 |
| 2025-10-2806:52 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001818331-25-000130 |
| 2025-10-2806:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000128 |
| 2025-09-1808:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001818331-25-000121 |
| 2025-08-2611:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-005136 |
| 2025-07-2908:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001818331-25-000108 |
| 2025-07-2907:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000105 |
| 2025-06-1816:11 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818331-25-000086 |
| 2025-05-0716:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001315863-25-000377 |
| 2025-04-3016:33 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001818331-25-000075 |
| 2025-04-3007:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001818331-25-000071 |
| 2025-04-3007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000070 |
| 2025-04-1607:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000057 |
| 2025-02-2116:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-024904 |
| 2025-02-2007:59 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001818331-25-000021 |
| 2025-02-1820:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-022688 |
| 2025-02-1806:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000013 |
| 2025-01-1308:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000004 |
| 2025-01-0217:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000002 |
| 2024-11-1920:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-24-000216 |
| 2024-11-0417:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-24-000180 |
| 2024-10-2908:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001818331-24-000059 |
| 2024-10-2908:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000057 |
| 2024-07-3016:19 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001818331-24-000042 |
| 2024-07-3016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000041 |
| 2024-06-2416:36 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818331-24-000036 |
| 2024-05-3116:55 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-003430 |
| 2024-04-2917:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001818331-24-000031 |
| 2024-04-2916:19 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001818331-24-000025 |
| 2024-04-2916:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001818331-24-000023 |
| 2024-04-2916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000021 |
| 2024-02-2316:56 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001818331-24-000008 |
| 2024-02-2016:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000006 |
| 2024-01-0808:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-24-000003 |
| 2023-11-1716:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-23-088332 |
| 2023-11-0316:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001818331-23-000068 |
| 2023-10-3016:33 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001818331-23-000066 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.